Speakers

GLOBAL LEADERS FROM PHARMA & BIOTECH

Bhakti Mehta

Executive Medical Director, Hematology Oncology Global Development

Amgen Inc.

Joshua Kapp

Senior Medical Scientist - Global Medical Oncology

Amgen Inc.

Josie Hayes

Director, Head of Translational Medicine

Revolution Medicines Inc.

Michael Shaghafi

Associate Director of Innovation & Discovery Chemistry

Frontier Medicines

Marco Hofmann

Director - Scientific & Group Leader

Boehringer Ingelheim

Mark Gelder

Chief Medical Officer

Onconova Therapeutics Inc

Vidya Balachander

Associate Director

Bristol Myers Squibb

Joshua Mason

Director

Mirati

Camilo Velez-Vega

AD & Senior Principal Scientist

Novartis AG

Steve kelsey

President

Revolution Medicines

Loic Vincent

Chief Scientific Officer

Affini-T Therapeutics

Erik Digman Wiklund

Chief Executive Officer

Targovax

Duncan Walker

Chief Development Officer

OnKure Inc.

Jonathan Pachter

CSO

Verastem. inc

Andrea Gohlke

Associate Principal Scientist

AstraZeneca

Frederic Reu

Vice President - Early Clinical Development

Deciphera Pharmaceuticals

Marco Maruggi

Principal Scientist

Pfizer

Imran Khan

Senior Scientist

Bristol Myers Squibb

Colin Weekes

Director, Pancreatic Cancer Research, The Tucker Gosnell Center for Gastrointestinal Cancers, Massachusetts General Hospital

Harvard Medical School  

Lusong Luo

Senior Vice President, External Innovation

BeiGene

Scott Loughhead

Senior Director of Immuno-Oncology Research

SQZ Biotechnologies

Peter DeMuth

Chief Scientific Officer

Elicio Therapeutics

Klaus Orlinger

Chief Scientific Officer

Hookipa Biotech

Robert Pelham

Vice President, Translational Medicine,

Kinnate Biopharma Inc.

Chowdary Dondapati

US Head of Diagnostic Marketing, Precision Medicine

Bayer

Terri Conneran

KRAS Cancer Survivor, Founding Director

KRAS Kickers

Sam Shrivastava

Chief Executive Officer

ASHA therapeutics

Andrew Whale

Associate Director, Pipeline Biology

Immunocore Ltd

Ana Limon

Senior Vice President- Clinical Development & Medical Affairs

Oryzon Genomics

Trevor Pitcher

Director of Medical Affairs

Biodesix Inc

Antreas Hindoyan

Senior Principal Scientist

Amgen Inc.

Kevin Pong

Chief Business Officer

Anima Biotech

Greg Jones

Principal Scientist

Pfizer

Andrea wang-gillam

Chief Medical Officer

Jacobio Pharmaceuticals Inc

Samuel Wickline

Chief Scientific Officer

Altamira Therapeutics

PIONEERING ACADEMICS

Andrew Aguirre

Physician Scientist & Medical Oncologist

Dana-Farber Cancer Institute

Chiara Ambrogio

Associate Professor of, Molecular Biology

University of Turin

Richard Kim

Service Chief of Medical Gastrointestinal Oncology

Moffitt Cancer Center

Scott Kopetz

Professor

MD Anderson Cancer Center

Christopher Counter

Professor

Duke University

Dhirendra Simanshu

Principal Scientist - Structural Biology, RAS Initiative & Group Lead

Frederick National Laboratory for Cancer Research

Nancy Ratner

Co-Leader, Rasopathy Program, Professor of Pediatrics

Cincinnati Childrens Hospital Medical Center

Rob Kortum

Assistant Professor

Uniformed Services University of the Health Sciences - USUHS

Arvin Dar

Professor

Icahn School of Medicine at Mount Sinai

Dafna Bar-Sagi

Chief Scientific Officer, Executive Vice President & Vice Dean - Science

nyu langone health

David Hong

Deputy Chair, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine

MD Anderson Cancer Center

John O’Bryan

Professor - Cell, Molecular Pharmacology & Experimental Therapeutics

Medical University of South Carolina

Channing Der

Sarah Graham Kenan Distinguished Professor

University of North Carolina - Chapel Hill

Ziyang Zhang

Assistant Professor

University of Califorina, San Francisco